Brief: Harvard Bioscience Q1 Adjusted Loss Per Share $0.01
Harvard Bioscience Inc HBIO.O :
* HARVARD BIOSCIENCE ANNOUNCES FIRST QUARTER 2020 FINANCIAL
RESULTS
* Q1 ADJUSTED LOSS PER SHARE $0.01
* Q1 LOSS PER SHARE $0.12
* Q1 REVENUE $23.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$27.9
MILLION
* SEES Q2 REVENUE DOWN ABOUT 20 TO 30 PERCENT
* Q1 EARNINGS PER SHARE ESTIMATE $0.03 -- REFINITIV IBES
DATA
* WITHDRAWING FULL-YEAR 2020 FINANCIAL GUIDANCE PREVIOUSLY
PROVIDED ON FEBRUARY 26
Source text for Eikon: ID:nGNXbdvKtF
Further company coverage: HBIO.O
Recent news on Harvard Bioscience
See all newsBrief: Harvard Bioscience Announces Creation Of Scientific Advisory Board
Harvard Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook
Harvard Bioscience Inc expected to post a loss of 21 cents a share - Earnings Preview
Harvard Bioscience Q1 revenue falls, reaffirms 2026 guidance